How can I manage Follicular Lymphoma treatment side effects

According to the NCCN Guidelines for Patients with Follicular Lymphoma (2024), here are the key approaches to managing side effects:

1. Communication with Care Team:

• It's essential to tell your care team about any new or worsening symptoms
• They can often provide ways to help the patient feel better or prevent certain side effects
• The care team will monitor side effects closely throughout treatment

1. Specific Side Effects to Watch For: According to NCCN Guidelines, common side effects include:

• Pain (which may require consultation with a palliative care or pain specialist)
• Weight gain (particularly from high-dose steroids)
• Tumor lysis syndrome (a condition requiring careful monitoring of blood chemistry)
• Therapy-related toxicity

1. Support System Recommendations: NCCN Guidelines specifically recommend:

• Seeking support groups at local hospitals
• Connecting with social media support communities
• Engaging friends, relatives, neighbors, and coworkers for social support
• Maintaining physical activity when possible

1. Proactive Management Steps: The NCCN Guidelines emphasize:

• Taking care of basic health through good nutrition
• Drinking plenty of fluids
• Engaging in appropriate exercise
• Participating in activities that provide energy

Important Note: NCCN Guidelines stress that "supportive care is health care given to prevent, reduce, and relieve suffering, and to improve quality of life." This may include:

• Pain relief
• Emotional or spiritual support
• Financial aid
• Family counseling

Remember: As a caregiver, you play a crucial role in monitoring and reporting side effects. The NCCN Guidelines emphasize that "you know your body better than anyone" - this applies to observing changes in the person you're caring for as well.

Always consult with the healthcare team before making any changes to manage side effects, as they can provide personalized recommendations based on the specific treatment plan and individual circumstances.

Sources:

• NCCN Guidelines for Patients: Follicular Lymphoma (2024), Section 36
• NCCN Guidelines for Patients: Follicular Lymphoma (2024), Section 40
• NCCN Guidelines for Patients: Follicular Lymphoma (2024), Section 41